1. Home
  2. INBS vs OXBR Comparison

INBS vs OXBR Comparison

Compare INBS & OXBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intelligent Bio Solutions Inc.

INBS

Intelligent Bio Solutions Inc.

N/A

Current Price

$1.69

Market Cap

6.5M

Sector

Health Care

ML Signal

N/A

Logo Oxbridge Re Holdings Limited

OXBR

Oxbridge Re Holdings Limited

N/A

Current Price

$0.70

Market Cap

7.7M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
INBS
OXBR
Founded
2016
2013
Country
United States
Cayman Islands
Employees
N/A
N/A
Industry
Medical Specialities
Property-Casualty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
6.5M
7.7M
IPO Year
2019
2014

Fundamental Metrics

Financial Performance
Metric
INBS
OXBR
Price
$1.69
$0.70
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 30.9K
20.1K
Earning Date
11-11-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 37.78
EPS
N/A
★ 0.02
Revenue
$1,980,484.00
★ $2,577,000.00
Revenue This Year
$44.72
N/A
Revenue Next Year
$44.26
N/A
P/E Ratio
★ N/A
$34.50
Revenue Growth
N/A
★ 371.98
52 Week Low
$0.54
$0.66
52 Week High
$24.90
$1.86

Technical Indicators

Market Signals
Indicator
INBS
OXBR
Relative Strength Index (RSI) 49.82 33.25
Support Level $1.52 $0.72
Resistance Level $1.92 $0.98
Average True Range (ATR) 0.10 0.13
MACD 0.04 -0.02
Stochastic Oscillator 80.95 20.25

Price Performance

Historical Comparison
INBS
OXBR

About INBS Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its current active product is the Intelligent Fingerprinting Platform, consisting of a proprietary portable platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader. Its flagship product, the Intelligent Fingerprinting Drug Screening System, is a two-part system of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse, including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Company operates in APAC, the UK, the Americas, and the rest of the world, with maximum revenue from the United Kingdom.

About OXBR Oxbridge Re Holdings Limited

Oxbridge Re Holdings Ltd is a holding company operating complementary growth platforms across AI infrastructure and digital financial infrastructure. Through AI GridWorks, the Company is focused on developing, owning, and operating AI data centers and related infrastructure. Through SurancePlus and its reinsurance subsidiaries, Oxbridge provides tokenized real-world asset (RWA) securities and reinsurance solutions, including tokenized reinsurance offerings utilizing blockchain technology.

Share on Social Networks: